Howard McClurd is a kidney cancer patient and advocate. Here are his thoughts from the 2020 ASCO GU Symposium. 

The first impression I had upon arrival is — this is overwhelming! 4,000 oncology specialists gathered to share updated clinical findings across a broad variety of topics in the Genitourinary Cancer space.

Bryan Lewis, President of KidneyCAN, with Dr. Hans Hammers, Dr. Bradley McGregor, and Dr. Toni Choueiri at at the 2020 Genitourinary Cancers Symposium

Bryan Lewis, President of KidneyCAN, with Dr. Hans Hammers, Dr. Bradley McGregor, and Dr. Toni Choueiri at at the 2020 Genitourinary Cancers Symposium in San Francisco.

 

Some of the topics may surprise or impress you as they did me, including:

  • The introduction of AI: Artificial Intelligence has made its way into cancer research, bringing new learning applications and innovative strategies for patient care.
  • Biomarkers and the influence of germline testing for the future of precision oncology. This use must be considered in parallel with somatic next-generation sequencing to guide targeted therapies for patients.
  • Combination therapies show promising benefits for second-line treatments (and possibly first line in the future).  Doctors shared successes with combining radiation and drug treatments, along with hypofractionation and SABR radiotherapy. They discussed the benefits of more pinpointed radiation treatment to reduce and possibly eliminate damage to tissue outside the affected areas of the cancer tumors.

  • Immunotherapy has truly shifted into the forefront!  More research is needed, and many spoke of the need to release this potential treatment.  Doctors are having great success already, but we have only scratched the surface of this technology.
  • Therapeutic trials are growing, and we need more participation.  This topic came up quite a bit during presentations and discussions.  As a patient advocate, my primary goal is to help find a cure, and to make this happen, we must emphasize the significance of these trials.  Drop the stigma associated with “trials,” and let’s inform patients how they can find trials, qualify for them, and participate.
San Francisco, CA - 2020 Genitourinary Cancers Symposium – Toni K. Choueiri, MD, presents Abstract 611 during Oral Abstract Session C: Renal Cell Cancer at the 2020 Genitourinary Cancers Symposium here today, Saturday February 15, 2020. Photo by © ASCO/Todd Buchanan 2020

Toni K. Choueiri, MD, presents Abstract 611 during Oral Abstract Session C: Renal Cell Cancer at the 2020 Genitourinary Cancers Symposium. Photo by © ASCO/Todd Buchanan 2020.

I am looking forward to learning more in this world of oncology.  I hope to share successes with the kidney cancer community and bring hope for future cancer survivors like me.

– Howard McClurd

San Francisco, CA - 2020 Genitourinary Cancers Symposium – Hans J. Hammers, MD, PhD, presents Abstract 614 during Oral Abstract Session C: Renal Cell Cancer at the 2020 Genitourinary Cancers Symposium here today, Saturday February 15, 2020. Photo by © ASCO/Todd Buchanan 2020

Hans J. Hammers, MD, PhD, presents Abstract 614 during Oral Abstract Session C: Renal Cell Cancer at the 2020 Genitourinary Cancers Symposium. Photo by © ASCO/Todd Buchanan 2020.

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORY BOARD →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for robust funding of kidney cancer...

FACING KIDNEY CANCER →

DIAGNOSIS →

BUILDING A CARE TEAM →

LEARN ABOUT CLINICAL TRIALS →

LIVING WELL WITH KIDNEY CANCER →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...

KCRS →

RESEARCH OPPORTUNITIES →

ADVOCATE WITH KIDNEYCAN →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for robust funding of kidney cancer...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Shari Stonacek: So Many Reasons to Live

Shari Stonacek: So Many Reasons to Live

Shari Stonacek is living with Stage IV kidney cancer. She is pictured here (center) with her family from left to right: daughter Joycin, daughter Jasmin, son-in-law Jordan, daughter-in-law Rachel holding grandson Landon, son Justin, Shari, husband Troy, daughter Joslin holding granddaughter...